Prescription drug · BLA
Lyumjev (insulin lispro-aabc) NDC 0002-7728
Insulin lispro 100 [iU]/mL · Injection, Solution · Intravenous, Subcutaneous · Eli Lilly and Company
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0002-7728-01 | 00002772801 | 1 VIAL, MULTI-DOSE in 1 CARTON (0002-7728-01) / 10 mL in 1 VIAL, MULTI-DOSEMarketed from Jun 15, 2020 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Lyumjev
- Generic name (nonproprietary)
- insulin lispro-aabc
- Active ingredients
- Insulin lispro — 100 [iU]/mL
- Dosage form
- Injection, Solution
- Route
- Intravenous, Subcutaneous
- Labeler
- Eli Lilly and Company
- Product type
- Prescription drug
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 761109
- Marketing start
- Listing expires
- Other FDA classes
- Insulin (Chemical/Ingredient)
- Identifiers
- Product ID 0002-7728_965b6bd6-37d4-451e-8c41-4df16df442d1SPL ID 965b6bd6-37d4-451e-8c41-4df16df442d1SPL set ID c5a056e2-b568-4ca6-9ed8-79c010942d00RxCUI 2380231, 2380236, 2380248, 2380250, 2380254, 2380256, 2380259, 2380260, 2380265, 2380266, 2380267, 2380268UNII GFX7QIS1II
- Pharmacologic class
- Insulin Analog
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N400002772801followed by a unit qualifier and the quantityPackage 00002-7728-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
LYUMJEV ® is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. LYUMJEV ® is a rapid-acting human insulin analog indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. ( 1 )
Excerpt only. Read the full label for complete information.
Other NDCs under BLA 761109
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Lyumjevinsulin lispro-aabc | Insulin lispro 100 [iU]/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-7726 |
| Lyumjevinsulin lispro-aabc | Insulin lispro 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | A-S Medication Solutions | 50090-7433 |
| LYUMJEV Junior KwikPeninsulin lispro-aabc | Insulin lispro 100 [iU]/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-8351 |
| LYUMJEV KwikPeninsulin lispro-aabc | Insulin lispro 100 [iU]/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-8207 |
| LYUMJEV Tempo Peninsulin lispro-aabc | Insulin lispro 100 [iU]/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-8235 |
| LYUMJEV KwikPeninsulin lispro-aabc | Insulin lispro 200 [iU]/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-8228 |